Related Experiment Videos

The molecular basis of C6 deficiency in the western Cape, South Africa

M J Hobart1, B A Fernie, K A Fijen

  • 1Molecular Immunopathology Unit, Medical Research Council Centre, Cambridge, UK. mhobart@dmu.ac.uk

Human Genetics
|December 18, 1998
PubMed

Insights

Three genetic defects cause total complement component 6 (C6) deficiency in South Africa, with a novel 879delG mutation being most common. These findings explain C6 deficiency in 38 individuals and suggest distinct origins for some mutations.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Human Genetics

Background:

  • Total deficiency of the sixth component of human complement (C6) is rare and linked to recurrent infections.
  • C6 deficiency is prevalent in families from the western Cape, South Africa, often identified due to meningococcal disease.

Purpose of the Study:

  • To identify the molecular basis of total C6 deficiency (C6Q0) in South African populations.
  • To investigate the origins and prevalence of specific C6 gene mutations in the western Cape.

Main Methods:

  • Sequencing of expressed exons of the C6 gene in individuals with C6 deficiency.
  • Analysis of C6/C7 region DNA marker haplotypes to trace mutation origins.
  • Comparison of identified mutations and haplotypes with previously reported cases.

Main Results:

  • Three molecular defects causing C6Q0 were identified: 879delG (novel, common in the Cape), 1195delC, and 1936delG (previously reported in African-Americans).
  • The 879delG and 1195delC mutations were associated with specific DNA haplotypes, indicating common ancestry.
  • These three defects explain C6Q0 in all 38 unrelated individuals studied from the Cape; 879delG was also found in Dutch kindreds.

Conclusions:

  • The identified molecular defects, particularly 879delG, account for total C6 deficiency in the western Cape population.
  • Haplotype analysis suggests distinct origins for some C6 deficiency mutations, with the Cape's 879delG likely not originating from the Netherlands.
  • Understanding these genetic defects is crucial for managing C6-deficient individuals, especially in regions with endemic meningococcal disease.

Related Concept Videos